THE BOTTOM LINE

As the pharmaceutical industry faces increasing pressures, firms must maximize returns from research and development while managing operational costs. Nucleus found Lilly’s subscription to Elsevier SciVerse ScienceDirect enabled it to manage operational research costs while providing researchers and other users with immediate access to information to make critical decisions.
ROI: 394%
Payback: 3.3 months